Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease
Authors:
- 27 October 2017
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 25 (1) , 290-298
Abstract
The Ki-67 index is an established prognostic marker for recurrence after resection of pancreatic neuroendocrine tumors (PanNETs) that groups tumors into three categories: low grade (< 3%), intermediate grade (3–20%), and high grade (> 20%). Given that the majority of resected PanNETs have a Ki-67 less than 3%, this study aimed to stratify this group further to predict disease recurrence more accurately.Keywords
Funding Information
- Jerold B Katz Foundation
This publication has 24 references indexed in Scilit:
- Chromogranin A predicts survival for resected pancreatic neuroendocrine tumorsJournal of Surgical Research, 2016
- How reliable is the Ki‐67 cytological index in grading pancreatic neuroendocrine tumors? A meta‐analysisJournal of Digestive Diseases, 2016
- Poorly Differentiated Neuroendocrine Carcinomas of the PancreasAmerican Journal of Surgical Pathology, 2014
- Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumorsScandinavian Journal of Gastroenterology, 2014
- Management of Pancreatic Neuroendocrine TumorsSurgical Clinics of North America, 2013
- Ki‐67 labeling: A more sensitive indicator of malignant phenotype than mitotic count or tumor size?Journal of Surgical Oncology, 2012
- Surgical management of pancreatic neuroendocrine tumorsSurgery Today, 2011
- Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parametersEndocrine-Related Cancer, 2010
- Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine TumorsGastroenterology, 2008
- Predicting Prognosis in Gastroentero-Pancreatic Neuroendocrine Tumors: An Overview and the Value of Ki-67 ImmunostainingEndocrine Pathology, 2008